BMY - Bristol-Myers Squibb Company

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 138.61B
Enterprise Value 168.72B
Trailing P/E 19.24
Forward P/E 8.14
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.07
Price/Book (mrq)4.36
Enterprise Value/Revenue 3.68
Enterprise Value/EBITDA 8.39

Trading Information

Stock Price History

Beta (5Y Monthly) 0.43
52-Week Change 3-13.85%
S&P500 52-Week Change 32.72%
52 Week High 381.44
52 Week Low 363.07
50-Day Moving Average 367.97
200-Day Moving Average 371.52

Share Statistics

Avg Vol (3 month) 38.17M
Avg Vol (10 day) 38.68M
Shares Outstanding 52.1B
Implied Shares Outstanding 6N/A
Float 82.1B
% Held by Insiders 10.07%
% Held by Institutions 178.62%
Shares Short (May 14, 2023) 421.49M
Short Ratio (May 14, 2023) 42.68
Short % of Float (May 14, 2023) 41.02%
Short % of Shares Outstanding (May 14, 2023) 41.02%
Shares Short (prior month Apr 13, 2023) 417.88M

Dividends & Splits

Forward Annual Dividend Rate 42.28
Forward Annual Dividend Yield 43.53%
Trailing Annual Dividend Rate 32.22
Trailing Annual Dividend Yield 33.36%
5 Year Average Dividend Yield 43.02
Payout Ratio 464.72%
Dividend Date 3Apr 30, 2023
Ex-Dividend Date 4Apr 05, 2023
Last Split Factor 21000000:951777
Last Split Date 3Aug 06, 2001

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 15.95%
Operating Margin (ttm)20.80%

Management Effectiveness

Return on Assets (ttm)6.04%
Return on Equity (ttm)23.07%

Income Statement

Revenue (ttm)45.85B
Revenue Per Share (ttm)21.64
Quarterly Revenue Growth (yoy)-2.70%
Gross Profit (ttm)36.38B
Net Income Avi to Common (ttm)7.31B
Diluted EPS (ttm)3.48
Quarterly Earnings Growth (yoy)77.00%

Balance Sheet

Total Cash (mrq)9.27B
Total Cash Per Share (mrq)4.41
Total Debt (mrq)39.39B
Total Debt/Equity (mrq)123.52
Current Ratio (mrq)1.42
Book Value Per Share (mrq)15.15

Cash Flow Statement

Operating Cash Flow (ttm)12.22B
Levered Free Cash Flow (ttm)12.6B